View
About the views

Guided View. New to dividends? Yields, ex-dividend dates, payout ratios, DRIP: we explain every term as you browse, in plain English. Same data, with the help built in.

Expert View. You already know the market. Just the data: clean, fast and compact, with no extra explanations. This is the default view.

Theme
Dividendly Independent dividend research

← Back to declarations

GEHC GE HealthCare Technologies Inc. — dividend yield, history & ex-dividend dates

NASDAQ Global Select· Quarterly dividend· Common Stock · Healthcare / Medical - Devices

$76.42 ▲ $0.60(0.79%) as of Oct 30, 2026 06:20 UTC
Sponsored Advanced charts & data →

GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division specializes in advanced diagnostic imaging technologies, including systems for molecular imaging, Computed Tomography (CT) scans, Magnetic Resonance (MR) imaging, image-guided therapy, and X-ray, alongside specialized women's health products. The Ultrasound segment delivers a comprehensive suite of ultrasound solutions utilized for the screening, diagnosis, treatment, and monitoring of various diseases. These applications span radiology, primary care, women's health, cardiovascular diagnostics, point-of-care, and portable handheld devices, in addition to products supporting surgical visualization and guidance. The Patient Care Solutions segment is dedicated to providing essential medical devices, consumable products, services, and digital platforms. Its portfolio encompasses patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal-infant care products. The Pharmaceutical Diagnostics segment supplies specialized diagnostic agents to the radiology and nuclear medicine industries. These include contrast media pharmaceuticals, administered to patients prior to scans like CT, angiography, X-ray, and MR, to enhance the visibility of internal tissues and structures. It also offers molecular imaging agents, or radiopharmaceuticals – molecular tracers labeled with radioisotopes – injected into patients for advanced diagnostic imaging applications such as Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and specific ultrasound procedures. Established in 2022, GE HealthCare Technologies Inc. maintains its corporate headquarters in Chicago, Illinois.

Dividend Snapshot

StatusRecently Increased
Last Dividend$0.0400Pays Nov 13, 2026
Forward Annual$0.16From the $0.0400 dividend declared Sep 22, 2026
FrequencyQuarterly
Last Ex-DateOct 23, 2026The most recent ex-dividend date that has already passed.
1-Yr Growth16.7%Annual totals, 2024–2025

Research Scores

Scores describe this security's published financial data on a 0–100 scale using the formulas on our methodology pages. They are the same for every reader, are not a probability or a forecast, and are not a recommendation. Past dividend growth does not guarantee future increases. Report a data error.

Dividend Safety Score

82/100

Very strong indicators

Complete data

Dividend Growth Score

63/100

Strong growth record

Partial data

Dividend Value Score

66/100

Below own historical valuation

Complete data

DividendRank

71/100

Upper middle of the scale

Most data available

How the Dividend Safety Score is built for GEHC
InputValuePointsWeight
Earnings payout ratioEarnings payout ratio 2% (TTM to Jun 30, 2026) 100 20%
FCF payout ratioFCF payout ratio 5% (TTM to Jun 30, 2026) 100 25%
Net debt / EBITDANet debt / EBITDA 2.2x (TTM to Jun 30, 2026) 81 15%
Interest coverageInterest coverage 7.0x (TTM to Jun 30, 2026) 79 10%
Dividend record3 years of uninterrupted regular payments 33 20%
Earnings stabilityNet income positive in 5 of the last 5 fiscal years (FY2021–FY2025) 100 10%

Inputs that are not available are left out and the remaining weights are scaled up. Profile: ordinary company. Formula version 2026-10-19.4.

How the Dividend Growth Score is built for GEHC
InputValuePointsWeight
5-year dividend growthN/A (not used) N/A 25%
Consecutive annual increases1 consecutive annual increase (through 2025) 25 20%
Payout headroomHeadroom from the earnings payout ratio 2% (TTM to Jun 30, 2026) 100 20%
Earnings per share growth (3 years)EPS CAGR 2.5% (FY2022–FY2025) 58 15%
Revenue growth (3 years)Revenue CAGR 4.0% (FY2022–FY2025) 75 10%
10-year dividend growthN/A (not used) N/A 10%

Inputs that are not available are left out and the remaining weights are scaled up. Profile: ordinary company. Formula version 2026-10-19.4.

How the Dividend Value Score is built for GEHC
InputValuePointsWeight
Yield vs own historyYield 0.20% is 1.16x its average of 0.17% (28 months of history) 71 40%
P/E vs own 5-year medianP/E 16.4 is 0.91x its 5-year median of 18.0 63 25%
FCF yieldFCF yield 2.6% (TTM to Jun 30, 2026) 34 20%
P/E vs peersP/E 16.4 vs peer median 26.8 (0.61x; 45 corporation / Healthcare securities) 98 15%

Inputs that are not available are left out and the remaining weights are scaled up. Profile: ordinary company. Formula version 2026-10-19.4.

Key Metrics

Current Yield

0.21%

At the Oct 30, 2026 price

The annual dividend as a percentage of the share price. A 3% yield is about $3 of dividends a year for every $100 invested at today's price.

Annualized Dividend

$0.1600

Declared Sep 22, 2026

The latest declared regular dividend scaled to a full year by how often it's paid (for semi-annual payers, the latest two payments), adjusted for stock splits. A $0.25 quarterly dividend annualizes to $1.00. Special dividends are excluded.

Frequency

Q Quarterly

How often the dividend is paid, read from the dates of recent payments: Q = quarterly (4x a year), M = monthly, S = semi-annual, A = annual.

RSI (14)

74

As of Oct 30, 2026

Relative Strength Index (0-100), a price-momentum gauge. Above 70 is often called 'overbought', below 30 'oversold'. A technical signal, not a dividend metric.

52-Week Range

$59.49 – $88.16

Closes through Oct 23, 2026

The lowest and highest price over the past year, showing where today's price sits in its recent range.

Payout Ratio (TTM)

4.02%

12 months to Jun 30, 2026 (Q2 FY2026)

The share of earnings paid out as dividends over the trailing twelve months (TTM): dividends paid divided by net income across the company's four most recent reported quarters, dated by the latest quarter end. A fiscal-year tag such as FY2025 means only annual figures were available. Lower leaves more cushion; above 100% means paying out more than the company earned. It shows n/a for funds and when net income over the period was negative; for REITs and BDCs it is marked EPS-based, since they are judged on FFO/AFFO or net investment income instead.

Years Paying

3

How many years of payments we have on record. This can understate very long histories where our data doesn't reach far enough back.

Price / Book (TTM)

2.95

Price as of Oct 25, 2026; latest reported book value

Price-to-book ratio: the share price on the date shown divided by the latest reported book value per share. A rough valuation gauge, most useful for asset-heavy sectors like REITs, banks and insurers.

S.A.F.E. Dividend Read

S.A.F.E. is a set of four checks on a dividend's record and the company's data, the same test used across the screener and our ranked lists. Solid: a Dividend Safety Score of 70+ and a yield of 2%+. Accelerating: at least three consecutive completed calendar years of higher total regular dividends. Flawless: since 1990, no calendar year whose total regular dividend fell more than 20% below the year before, and no suspension. Enduring: at least 20 years between the first and latest dividend in our records. All four met earns the S.A.F.E. flag.
S Solid
Below the Solid check (Dividend Safety Score 70+ and yield 2%+): Dividend Safety Score 82/100, yield 0.21%.
A Accelerating
Dividend growth has stalled — 1 consecutive annual increase(s), under the 3 this check looks for.
F Flawless
No calendar year's regular dividend total fell more than 20% below the year before, and no suspension of the regular dividend is on record.
E Enduring
3 year(s) of payments on record, under the 20 this check looks for.

Quote & Key Data

ExchangeNASDAQ Global SelectThe stock exchange where the shares trade, such as NYSE or Nasdaq.
Volume2,976,197Oct 23, 2026 sessionHow many shares changed hands in the trading session dated beside this figure, a rough read on trading activity. Daily bars are refreshed on a slower cycle than the quoted price, so this session can be older than the price above.
Open$70.74Oct 23, 2026 sessionThe price at the start of the trading session dated beside this figure, which can be earlier than the session the quoted price comes from.
Day Range$70.10 – $71.86Oct 23, 2026 sessionThe lowest and highest price during the trading session dated beside this figure, which can be earlier than the session the quoted price comes from.
Prev Close$71.42Close of Oct 22, 2026The closing price from the session before the one dated beside these figures.
Market Cap$34.52BAs of Oct 30, 2026The company's total market value (share price times shares outstanding) on the date shown.
Shares Out451.69MImplied by market cap, Oct 30, 2026Shares outstanding implied by the market cap and share price on the date shown.
EPS (TTM)$3.5112 months to Jun 30, 2026 (Q2 FY2026)Earnings per share over the trailing twelve months (TTM), labeled with the end date of the latest reported quarter and shown in the company's reporting currency. Dividends are paid out of these earnings.
P/E (TTM)20.5Price as of Oct 25, 2026; earnings to Jun 30, 2026Price-to-earnings ratio: the share price on the date shown divided by trailing-twelve-month earnings per share. A rough gauge of how richly the stock is valued.
Last Ex-DateOct 23, 2026Pays Nov 13, 2026The most recent ex-dividend date that has already passed.
Next Ex-DateN/ANone declared yetThe ex-dividend date of the next payment the company has declared, or that is scheduled when no declaration is on file. Future dates our data provider only projects are not shown.

Dividend Growth

3-Yr Growth (CAGR)N/AThe dividend's average annual growth rate over the period, compounded.
5-Yr Growth (CAGR)N/AThe dividend's average annual growth rate over the period, compounded.
Consecutive Increases1 yrAnnual totals through 2025The number of consecutive years the dividend has increased.

Why the Yield Moved (90 Days)

GEHC's dividend yield rose from 0.20% to 0.21% over the past ~90 days (+0.01 pp). Of that move, +0.03 pp came from changes in the dividend rate and -0.02 pp from the share price ($69.73 on Aug 03, 2026 → $76.42 on Oct 30, 2026). A yield that rises because the price fell is not an improvement in the payout itself.

Yield vs Its Own History

Current0.21%
1-Yr Average0.20%
Low / High0.16% – 0.25%
Percentile65%

Across 272 daily observations over the past 13 months (through Oct 23, 2026), GEHC's current yield is higher than approximately 65% of them. Our stored price history for GEHC covers the past 13 months; 3- and 5-year averages are not yet computable from it and are deliberately not shown.

Adjusted Price History

Dividend History

Dividend Payment History

Ex-dividend calendar →
Amount Type Declared Ex-Date Record Pay
$0.0400 Q Regular Sep 22, 2026 Oct 23, 2026 Oct 23, 2026 Nov 13, 2026
$0.0350 Q Regular Jun 30, 2026 Jul 24, 2026 Jul 24, 2026 Aug 14, 2026
$0.0350 Q Regular Feb 12, 2026 Apr 02, 2026 Apr 03, 2026 May 15, 2026
$0.0350 Q Regular Nov 24, 2025 Jan 09, 2026 Jan 09, 2026 Feb 13, 2026
$0.0350 Q Regular Sep 24, 2025 Oct 24, 2025 Oct 24, 2025 Nov 14, 2025
$0.0350 Q Regular Jul 01, 2025 Jul 25, 2025 Jul 25, 2025 Aug 15, 2025
$0.0350 Q Regular Mar 27, 2025 Apr 25, 2025 Apr 25, 2025 May 15, 2025
$0.0350 Q Regular Nov 21, 2024 Jan 14, 2025 Jan 14, 2025 Feb 14, 2025
$0.0300 Q Regular Sep 18, 2024 Oct 18, 2024 Oct 18, 2024 Nov 15, 2024
$0.0300 Q Regular Jun 26, 2024 Jul 19, 2024 Jul 19, 2024 Aug 15, 2024
$0.0300 Q Regular Mar 22, 2024 Apr 18, 2024 Apr 19, 2024 May 15, 2024
$0.0300 Q Regular Dec 08, 2023 Jan 12, 2024 Jan 16, 2024 Feb 15, 2024
$0.0300 Q Regular Sep 22, 2023 Oct 19, 2023 Oct 20, 2023 Nov 15, 2023
$0.0300 Q Regular Jun 23, 2023 Jul 20, 2023 Jul 21, 2023 Aug 15, 2023
$0.0300 Q Special Apr 25, 2023 May 22, 2023 May 23, 2023 Jun 15, 2023

Peer Comparison

Selected Medical - Devices dividend payers we cover, strongest DividendRank first — for context, not a recommendation.

TickerNameYield5-Yr GrowthStreakRank
STE STERIS plc 1.19% 9.3% 19 yrs 90
SYK Stryker Corporation 1.13% 7.6% 16 yrs 87
RMD ResMed Inc. 1.04% 7.7% 12 yrs 84
SNNUF Smith & Nephew plc 2.95% 0.4% 1 yr 81

Related Guides & Lists

GEHC dividend — frequently asked questions

Does GE HealthCare Technologies Inc. pay a dividend?

Yes. GE HealthCare Technologies Inc. (GEHC) currently pays a dividend. The annualized dividend is about $0.16 per share, a yield of approximately 0.21%.

What is GE HealthCare Technologies Inc.'s dividend yield?

GE HealthCare Technologies Inc.'s dividend yield is approximately 0.21%, based on the most recent regular payment annualized against the current share price. Yields move as the share price changes.

How often does GE HealthCare Technologies Inc. pay dividends?

GE HealthCare Technologies Inc. pays dividends quarterly — 4 times per year.

How long has GE HealthCare Technologies Inc. paid dividends?

GE HealthCare Technologies Inc. has 3 years of dividend payments on record.

Data updated Oct 30, 2026. This research page is generated from Dividendly's structured market and dividend dataset using the approach described on our methodology and data sources pages. Data is automatically validated using defined rules and may also be periodically reviewed. Research only, not investment advice. Spotted a data error? Report it.